REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,175 | -11.1% | 11,526 | -20.7% | 0.00% | 0.0% |
| Q1 2023 | $1,321 | +75.2% | 14,529 | -26.8% | 0.00% | +100.0% |
| Q4 2022 | $754 | -99.8% | 19,836 | -0.0% | 0.00% | 0.0% |
| Q3 2022 | $499,000 | -20.4% | 19,845 | -3.9% | 0.00% | 0.0% |
| Q2 2022 | $627,000 | -3.5% | 20,644 | +4.1% | 0.00% | 0.0% |
| Q1 2022 | $650,000 | +24.3% | 19,838 | -0.0% | 0.00% | 0.0% |
| Q4 2021 | $523,000 | -73.9% | 19,844 | -0.2% | 0.00% | -50.0% |
| Q3 2021 | $2,001,000 | -40.3% | 19,887 | -16.1% | 0.00% | -33.3% |
| Q2 2021 | $3,354,000 | +10.6% | 23,700 | -22.1% | 0.00% | 0.0% |
| Q1 2021 | $3,033,000 | -25.5% | 30,426 | -7.6% | 0.00% | -40.0% |
| Q4 2020 | $4,070,000 | +17.9% | 32,926 | -7.1% | 0.01% | +25.0% |
| Q3 2020 | $3,451,000 | -35.9% | 35,426 | +2.6% | 0.00% | -42.9% |
| Q2 2020 | $5,387,000 | +65.8% | 34,526 | +53.4% | 0.01% | +40.0% |
| Q1 2020 | $3,249,000 | -34.3% | 22,507 | -6.9% | 0.01% | -16.7% |
| Q4 2019 | $4,945,000 | +149.5% | 24,188 | -2.0% | 0.01% | +100.0% |
| Q3 2019 | $1,982,000 | -12.0% | 24,688 | +3.4% | 0.00% | 0.0% |
| Q2 2019 | $2,253,000 | +22.8% | 23,881 | +11.3% | 0.00% | +50.0% |
| Q1 2019 | $1,834,000 | +77.4% | 21,459 | +16.5% | 0.00% | +100.0% |
| Q4 2018 | $1,034,000 | -28.6% | 18,426 | +3.9% | 0.00% | -50.0% |
| Q3 2018 | $1,449,000 | +133.7% | 17,726 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $620,000 | +145.1% | 17,726 | +43.8% | 0.00% | – |
| Q1 2018 | $253,000 | -27.5% | 12,326 | 0.0% | 0.00% | – |
| Q4 2017 | $349,000 | +6.7% | 12,326 | +17.1% | 0.00% | – |
| Q3 2017 | $327,000 | -1.8% | 10,526 | 0.0% | 0.00% | – |
| Q2 2017 | $333,000 | +109.4% | 10,526 | +49.8% | 0.00% | – |
| Q1 2017 | $159,000 | +3.9% | 7,027 | +0.0% | 0.00% | – |
| Q4 2016 | $153,000 | -17.3% | 7,026 | 0.0% | 0.00% | – |
| Q3 2016 | $185,000 | +86.9% | 7,026 | +39.8% | 0.00% | – |
| Q2 2016 | $99,000 | – | 5,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |